Anthos Therapeutics Joins the World Thrombosis Day Campaign as a Supporter to Raise Awareness of Life-Threatening Blood Clots
September 22nd, 2022
CHAPEL HILL, NC, USA, September 22, 2022– The World Thrombosis Day campaign, observed annually on October 13, announced that the clinical-stage biopharmaceutical company, Anthos Therapeutics, joins the campaign’s global awareness initiative to reduce death and disability caused by thrombosis, also known as blood clots.
Led by the International Society on Thrombosis and Haemostasis (ISTH), World Thrombosis Day mobilizes more than 3,000 partner organizations to hold more than 10,000 awareness events worldwide each year. Last year alone, the campaign reached an estimated 5.2 billion people globally to shine a spotlight on the seriousness of the condition.
“We are honored to welcome Anthos Therapeutics as supporter of the campaign,” said Prof. Beverley Hunt, O.B.E., chair of the World Thrombosis Day Steering Committee. “We are excited to work together to increase awareness at all levels – individual, healthcare workers and healthcare providers – to collectively encourage prevention and to continue addressing blood clots as a largely preventable health problem.”
One in four deaths worldwide is related to thrombosis, highlighting the urgent need for awareness and patient empowerment to ask for a risk assessment. The campaign encourages the general public, healthcare professionals and key decision-makers to know and act on the risk factors, signs, and symptoms of thrombosis.
“We are proud to support the World Thrombosis Day campaign to raise awareness about the risks associated with thrombosis,” said Drew Young, Chief Commercial Officer and Head of Patient Experience at Anthos Therapeutics. “At Anthos, we are committed to scientific innovation and collaboration with societal partners to create life-changing therapies around the world. So, we are passionate about partnering with World Thrombosis Day to bring global awareness to the signs and symptoms of thrombosis to empower patients to access quick and appropriate treatment.”
To learn more and support World Thrombosis Day, visit www.worldthrombosisday.org.
About World Thrombosis Day
Launched in 2014 and held annually on 13 October, World Thrombosis Day (WTD) aims to increase public, healthcare professional and health care systems’ awareness of thrombosis and, ultimately, to reduce deaths and disabilities from thromboembolic disease through a greater awareness of its causes, risk factors, signs and symptoms, and evidence-based prevention and treatment. Our mission supports the World Health Assembly's global target of reducing premature deaths by non-communicable disease by 25 percent by 2025, as well as the World Health Organization’s Thirteenth General Programme of Work 2019–2023, the Montevideo Roadmap 2018-2030 on NCDs and the Political Declaration of UNGA' Third High-level Meeting on NCDs. Visit www.worldthrombosisday.org for more information and to get involved.
About the International Society on Thrombosis and Haemostasis (ISTH)
Founded in 1969, the ISTH is the leading worldwide not-for-profit organization dedicated to advancing the understanding, prevention, diagnosis, and treatment of conditions related to thrombosis and hemostasis. ISTH is an international medical-scientific professional membership organization with more than 7,500 clinicians, researchers, and educators working together to improve the lives of patients in more than 110 countries around the world. Among its highly regarded activities and initiatives are education and standardization programs, research activities, meetings and congresses, peer-reviewed publications, expert committees, and World Thrombosis Day on 13 October. Visit ISTH online at www.isth.org.
Media Relations Manager
The International Society on Thrombosis and Haemostasis (ISTH)